Literature DB >> 21812391

Assignment and stereocontrol of hibarimicin atropoisomers.

Ian M Romaine1, Jonathan E Hempel, Ganesh Shanmugam, Hiroshi Hori, Yasuhiro Igarashi, Prasad L Polavarapu, Gary A Sulikowski.   

Abstract

A stereochemical feature of the hibarimicins is a central biaryl (HMP-Y6) or aryl-quinone (hibarimicinone) incorporated as a single atropodiastereomer. Herein, a chiral resolution and deracemization process to access optically enriched biaryls aR-3 and aS-3 is described. From these atropoenantiomers the BCD-EFG ring system of HMP-Y6 is constructed [(+)-aR-7]. Comparison of CD spectra of aR-7 to HMP-Y6 leads to the assignment of HMP-Y6 and hibarimicin B atropoisomers as aR and aS, respectively.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21812391      PMCID: PMC3163008          DOI: 10.1021/ol2017005

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  29 in total

Review 1.  Atroposelective total synthesis of axially chiral biaryl natural products.

Authors:  Gerhard Bringmann; Tanja Gulder; Tobias A M Gulder; Matthias Breuning
Journal:  Chem Rev       Date:  2010-10-12       Impact factor: 60.622

2.  Atroposelective synthesis of axially chiral biaryl compounds.

Authors:  Gerhard Bringmann; Anne J Price Mortimer; Paul A Keller; Mary J Gresser; James Garner; Matthias Breuning
Journal:  Angew Chem Int Ed Engl       Date:  2005-08-26       Impact factor: 15.336

3.  The oxidation of organocuprates--an offbeat strategy for synthesis.

Authors:  David S Surry; David R Spring
Journal:  Chem Soc Rev       Date:  2005-12-16       Impact factor: 54.564

4.  Dynamic thermodynamic resolution: advantage by separation of equilibration and resolution.

Authors:  Won Koo Lee; Yong Sun Park; Peter Beak
Journal:  Acc Chem Res       Date:  2009-02-17       Impact factor: 22.384

5.  Signal transduction inhibitors, hibarimicins A, B, C, D and G produced by Microbispora. II. Structural studies.

Authors:  H Hori; Y Igarashi; T Kajiura; T Furumai; K Higashi; T Ishiyama; M Uramota; Y Uehara; T Oki
Journal:  J Antibiot (Tokyo)       Date:  1998-04       Impact factor: 2.649

6.  Biosynthesis of hibarimicins. III. Structures of new hibarimicin-related metabolites produced by blocked mutants.

Authors:  Yasuhiro Igarashi; Takayuki Kajiura; Tamotsu Furumai; Hiroshi Hori; Kazuaki Higashi; Tadayuki Ishiyama; Masakazu Uramoto; Yoshimasa Uehara; Toshikazu Oki
Journal:  J Antibiot (Tokyo)       Date:  2002-01       Impact factor: 2.649

7.  Studies into the stereoselectivity of tartrate-derived dienophiles.

Authors:  Wei-Der Lee; Kwangho Kim; Gary A Sulikowski
Journal:  Org Lett       Date:  2005-04-28       Impact factor: 6.005

8.  Optically active (aR)- and (aS)-linear and vaulted biaryl ligands: deracemization versus oxidative dimerization.

Authors:  Gang Hu; Daniel Holmes; Brina Fay Gendhar; William D Wulff
Journal:  J Am Chem Soc       Date:  2009-10-14       Impact factor: 15.419

9.  Biomimetic studies towards the cardinalins: synthesis of (+)-ventiloquinone L and an unusual dimerisation.

Authors:  Jonathan Sperry; Jimmy J P Sejberg; Frank M Stiemke; Margaret A Brimble
Journal:  Org Biomol Chem       Date:  2009-04-28       Impact factor: 3.876

10.  Signal transduction inhibitors, hibarimicins, A, B, C, D and G produced by Microbispora. I. Taxonomy, fermentation, isolation and physico-chemical and biological properties.

Authors:  T Kajiura; T Furumai; Y Igarashi; H Hori; K Higashi; T Ishiyama; M Uramoto; Y Uehara; T Oki
Journal:  J Antibiot (Tokyo)       Date:  1998-04       Impact factor: 2.649

View more
  4 in total

1.  Total syntheses of HMP-Y1, hibarimicinone, and HMP-P1.

Authors:  Brian B Liau; Benjamin C Milgram; Matthew D Shair
Journal:  J Am Chem Soc       Date:  2012-09-26       Impact factor: 15.419

2.  Gram-scale synthesis of the A'B'-subunit of angelmicin B.

Authors:  Benjamin C Milgram; Brian B Liau; Matthew D Shair
Journal:  Org Lett       Date:  2011-11-15       Impact factor: 6.005

3.  Second-Generation Synthesis of (-)-Viriditoxin.

Authors:  Charles I Grove; Jared T Shaw
Journal:  Synthesis (Stuttg)       Date:  2012       Impact factor: 3.157

4.  Studies on a biomimetic oxidative dimerization approach to the hibarimicins.

Authors:  Ian M Romaine; Gary A Sulikowski
Journal:  Tetrahedron Lett       Date:  2015-06-03       Impact factor: 2.415

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.